शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEINDRAYANI BIOTECH LTD.· Agricultural Food & other ProductsHighNegative
Announced Wed, 21 Oct, 2026 · 18:07 IST

Income Tax Recovery: Indrayani Biotech Files Response to About Rs 1.17 Crore Demand

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+3.5%Reaction day
₹8.68
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.0%+4.5% vs market
Other Agricultural Products peers, median of 60sector-0.6%+4.0% vs sector

On the reaction day the stock moved 4.5 pts more than Nifty Microcap 250 and 4.0 pts more than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+3.5-1.0+4.5-0.6+4.0
Next day
-3.9-3.3-0.6-2.2-1.7
2d
-8.4-2.9-5.5-2.4-6.0
3d
-4.4-1.3-3.1-1.6-2.8
4d
-5.0-1.2-3.8-2.2-2.8
5d
-10.0-0.5-9.5-1.2-8.8
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Other Agricultural Products peers, median of 60Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indrayani Biotech received an Income Tax recovery letter for outstanding demands totaling about Rs 1.17 crore across Assessment Years 2011-12, 2012-13 and 2013-14. The company has filed a detailed response with the Income Tax Department in Chennai. For AY 2013-14 (Rs 98.09 lakh), it points out that the ITAT had already set aside the original order in November 2020, so the demand should not survive. For AY 2011-12 and 2012-13 (Rs 18.45 lakh), a first appeal was filed in April 2022 and is still pending, and the company has requested recovery be kept in abeyance. Management states no immediate financial impact and strong legal grounds.

Likely market impact

No immediate financial hit claimed. Earlier ITAT ruling favours the company on one demand; outcome of pending appeal on the rest remains a key watchpoint.